2017
DOI: 10.1016/j.braindev.2017.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features in very early-onset demyelinating disease with anti-MOG antibody

Abstract: This case series adds novel information regarding the clinical features of children <4years old with ADS and the anti-MOG antibody.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Many demyelinating disease-associated antibodies have been described [3,4] as important diagnostic and prognostic biomarkers. [8,9], we here describe a Korean child with recurrent unilateral ONs and a single ADEM episode who showed high titers of MOG antibodies. This study was approved by the institutional review board of the Soonchunhyang University Bucheon Hospital with informed consent (2019-11-041).…”
Section: Introductionmentioning
confidence: 92%
“…Many demyelinating disease-associated antibodies have been described [3,4] as important diagnostic and prognostic biomarkers. [8,9], we here describe a Korean child with recurrent unilateral ONs and a single ADEM episode who showed high titers of MOG antibodies. This study was approved by the institutional review board of the Soonchunhyang University Bucheon Hospital with informed consent (2019-11-041).…”
Section: Introductionmentioning
confidence: 92%